Navigation Links
Accuray to Report Financial Results for Second Quarter Fiscal 2014
Date:1/7/2014

SUNNYVALE, Calif., Jan. 7, 2014 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that it will report results for its second quarter of fiscal 2014, ended December 31, 2013 on Thursday, January 30, 2014 after the market closes.

A conference call to review the results will begin at 1:30 p.m. PST/4:30 p.m. EST and will be hosted by Joshua H. Levine, president and chief executive officer and Gregory Lichtwardt, executive vice president, operations and chief financial officer both of Accuray.

The conference call dial-in numbers are 1-866-318-8618 (USA) or 1-617-399-5137 (International), Conference ID: 52092679. In addition, a dial-up replay of the conference call will be available beginning January 30, 2014 at 5:30 p.m. PST/8:30 p.m. EST and ending on February 6, 2014. The replay telephone number is 1-888-286-8010 (USA) or 1-617-801-6888 (International), Conference ID: 37382502.

A live webcast of the call will also be available from the Investor Relations section of the company's website at http://www.accuray.com/investors. A webcast replay can be accessed on the website beginning Thursday, January 30, 2014 at approximately 4:30 p.m. PST/7:30 p.m. EST. The replay will remain available until Accuray announces its results for the third quarter of fiscal 2014, ending March 31, 2014.

About Accuray
Accuray Incorporated (Nasdaq: ARAY), is a radiation oncology company that develops, manufactures and sells precise, innovative tumor treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. The Company's leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments. For more information, please visit www.accuray.com.


'/>"/>
SOURCE Accuray Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Accuray Surpasses 600 Installations Globally
2. Accuray Announces First CyberKnife System in South America
3. Acquisitions, Clinical Trial Results, Date Extensions and Financial Results - Research Report on Endo, Astex, Auxilium, Accuray, and BioScrip
4. Accuray Reports Financial Results for First Quarter of Fiscal Year 2014
5. Accuray to Present at Piper Jaffray 25th Annual Healthcare Conference
6. Accuray to Present at JP Morgan 32nd Annual Healthcare Conference
7. Palatin Technologies, Inc. to Report Fiscal Year 2012 First Quarter Results; Teleconference and Webcast to be held on November 15, 2011
8. Discovery Labs Reports Third Quarter Financial Results and Progress on Lead Programs
9. Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011
10. Interleukin Genetics Reports Third Quarter 2011 Financial Results
11. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... (PRWEB) , ... May 25, 2016 , ... Scientists at ... line options being tried for mesothelioma may be hampering the research that could lead ... research. Click here to read it now. , The team evaluated 98 ...
(Date:5/24/2016)... ... 24, 2016 , ... Cell therapies for a range of ... research at Worcester Polytechnic Institute (WPI) that yielded a newly patented method of ... The novel method, developed by WPI faculty members Raymond Page, PhD, professor of ...
(Date:5/23/2016)... ... May 23, 2016 , ... The need for blood donations in South Texas and across ... South Texas Blood & Tissue Center, blood donations are on the decline. In fact, donations ... are down 21 percent in South Texas in the last four years alone. , There ...
(Date:5/23/2016)... and LONDON , May 23, 2016 ... Frontage Boost Efficiency by 40% - Frontage Implement a ... Frontage Enforce Quality, Compliance and Traceability Within the Bioanalytical lab ... in the United States and ... be deployed across its laboratory facilities. In addition to serving as ...
Breaking Biology Technology:
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted ... quarter of 2015 The gross margin was 49% (27) ... the operating margin was 40% (-13) Earnings per share ... operations was SEK 249.9 M (21.2) , Outlook   ... M. The operating margin for 2016 is estimated to ...
(Date:4/26/2016)... , April 27, 2016 ... the  "Global Multi-modal Biometrics Market 2016-2020"  report to ... ) , The analysts forecast the ... CAGR of 15.49% during the period 2016-2020.  ... number of sectors such as the healthcare, BFSI, ...
(Date:4/15/2016)... 15, 2016  A new partnership announced today ... underwriting decisions in a fraction of the time ... and high-value life insurance policies to consumers without ... With Force Diagnostics, rapid testing (A1C, Cotinine and ... (blood pressure, weight, pulse, BMI, and activity data) ...
Breaking Biology News(10 mins):